(Q36062323)
Statements
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis (English)
Daniel J Crespin
Jerome J Federspiel
Daniel E Jonas
Joseph S Rossi
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference